Drug – bio-affecting and body treating compositions – Extract – body fluid – or cellular material of undetermined... – Digestive system
Patent
1993-04-19
1994-05-31
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Extract, body fluid, or cellular material of undetermined...
Digestive system
514 2, 514 21, 514893, 514894, A61K 35407
Patent
active
053167759
ABSTRACT:
A therapeutic method for treating hepatitis B infection. The method comprises administering a therapeutically-effective amount of a mammalian liver extract, the extract being characterized by being heat stable, insoluble in acetone and soluble in water, peptide or peptide fragment selected from the groups consisting of Sequence Identification Numbers 1-9.
REFERENCES:
patent: 3778510 (1973-12-01), Blonde
patent: 4148788 (1979-04-01), Wang
patent: 4420398 (1983-12-01), Castino
patent: 4426324 (1984-01-01), Meienhofer
patent: 4428938 (1984-01-01), Kisfaludy
patent: 4464355 (1984-08-01), Fabricius
patent: 4468379 (1984-08-01), Gottlieb
patent: 4537878 (1985-08-01), Plotnikoff
patent: 4595588 (1986-06-01), Baron
patent: 4595780 (1986-06-01), Ogata
patent: 4596798 (1986-06-01), Shipman, Jr.
patent: 4598095 (1986-07-01), Nishimura
patent: 4602037 (1986-07-01), Scherm
patent: 4603122 (1986-07-01), Blough
patent: 4603219 (1986-07-01), Verheyden
patent: 4604404 (1986-08-01), Munson, Jr.
patent: 4605658 (1986-08-01), Holy
patent: 4605659 (1986-08-01), Verheyden
patent: 4606917 (1986-08-01), Eppstein
patent: 4609661 (1986-09-01), Verheyden
patent: 4609662 (1986-09-01), Krenitsky
patent: 4612314 (1986-09-01), Verheyden
patent: 4614651 (1986-09-01), Jarvis, Jr.
patent: 4614731 (1986-09-01), Horecker
patent: 4617304 (1986-10-01), Ashton
patent: 4621140 (1986-11-01), Verheyden
patent: 4622430 (1986-11-01), Dekker
patent: 4625026 (1986-11-01), Kim
patent: 4626524 (1986-12-01), Server
patent: 4628063 (1986-12-01), Haines
patent: 4629811 (1986-12-01), Dominianni
patent: 4631149 (1986-12-01), Rinehart, Jr.
patent: 4644055 (1987-02-01), Brunelle
patent: 4668660 (1987-05-01), Paessens
patent: 4670437 (1987-06-01), Abdulla
patent: 4699898 (1987-10-01), Gottlieb
patent: 4708818 (1987-11-01), Montagnier
patent: 4710380 (1987-12-01), Gottlieb
Bush et al., "Muraceins-Muramyl Peptides Produced by Nocardia Oriental is As Angiotensin-Converting Enzyme Inhibitors: I. Taxonomy, Fermentation and Biological Properties," J. Antibiotics 37(4), 330-335 (1984)
Chomczynski, et al., "Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate-Phenol-Chloroform Extraction," Anal. Biochem. 162:156-159 (1987).
Jacobson, A. "Purification and Fractionation of Poly(A).sup.+ RNA," Meth. Enzymology 152:254-261 (1987).
Korba et al., "Use of a Standardized Cell Culture Assay to Assess Activities of Nucleoside Analogs Against Hepatitis B Virus Replication," Antiviral Res. 19:55-70 (1992).
Korba et al., "A Cell Culture Assay For Compounds Which Inhibit Hepatitis B Virus Replication," Antiviral Res. 15:217-228 (1991).
Mierendorf et al. "Direct Sequencing of Denatured Plasmid DNA," Meth. Enzymol. 152:556-562 (1987).
Andrews et al. JAMA, 146, 1107 (1951).
Barksdale, South. Med. Jour., 50, 1524 (1957).
Barksdale, et al., Virginia Medical Monthly, 81, 321 (1954).
Barrock, Medical Times, 1, (Aug. 1958).
Boreen, Minnesota Medicine, 25, 276 (1942).
Burks, Jr., Journal of the Louisiana Medical Society, 106, 92 (1954).
Burks, Jr. and Knox, Archives of Dermatology and Syphilology, 70 508 (1954).
Center for Disease Control, Dept. Health and Human Services, Chronic Fatigue Syndrome, Mar. 22, 1988.
Chase, Wall Street Journal, Apr. 28, 1988, at 14, at col. 1.
Gaskell, Brit. Med. J., p. 1037 (Jun. 11, 1949).
Gathings, Am. J. Surgery, 88, 429 (1954).
Gladner, Ann. N.Y. Aca. Sci 47.
Harris, et al., Oral Surgery, 7, 239 (1954).
Hellinger, et al., JAMA, 260, 971 (Aug. 19, 1988).
Heywood, Clinical Medicine, 3, 425 (1956).
Hjerten, Archives of Biochemistry and Biophysics, Suppl. 1, 147 (1962).
Hjerten and Mosbach, Analytical Biochemistry, 3, 109 (1962).
Holtman, Oral Surgery, 7, 12 (1954).
Judge, Proc. Soc. Exptl. Biol. Med., 123, 199 (1966).
Kozelka and Marshall, Clinical Medicine, 3, 245 (1956).
Kutapressin-Drug Package Insert, Kremers-Urban.
Li, et al., Nature, 219, 1163 (Sep. 14, 1968).
Li, et al., Proc. Soc. Exptl. Biol. Med., 114, 504 (1963).
Li, et al., Proc. Soc. Exptl. Biol. Med., 109, 534 (1962).
Li, et al., J. Nat'l Cancer Inst., 41, 1249 (Nov. 1968).
Li, et al., Ann. N.Y. Acad. Sci., 130, 374 (1965).
Lichtenstein and Stillians, Arch. Dermatology and Syphilology, 45, 595 (1942).
Lubowe, Clinical Medicine, 59, 8 (1952).
Marshall, et al., Am. J. Surgery, 90, 47 (1955).
Marshall, Maryland State Med. J., (Jun. 1960).
Marshall, Am. J. Surgery, 84(6), 675 (1952).
Marshall, and Schadeberg, Wisconsin Medical Journal, 49, 369 (1950).
Marshall and Schadeberg, Indian J. Veneral Diseases, 16, 89 (1950).
Marshall, J.M.A. Alabama, 13, 255 (1944).
Marshall, Mississippi Valley Med. J., 61, 172 (1939).
Marshall, Med. World, 57, 101 (1939).
Marshall, Northwest Medicine, 38, 467 (1939).
Marshall, J. Invest. Derm., 2, 105 (1939).
Marshall, A. J. Surgery, 448 (Oct. 1951.
Marshall, Medical Times, 70, 222 (1951).
Marshall, Indian J. Veneral Diseases and Dermatology, 20, 99 (1954).
Marshall, The Journal-Lancet, 60, 117 (1940).
Marshall, Minnesota Medicien, 25, 796 (1942).
Marshall, Arizone Medicine, 14(1), 11 (1957).
Marshall, Mississippi Valley Med. J., 76, 199 (1954).
Mitchell-Heggs, Brit. Med. J., 2, 1079 (1951).
Montefiori, et al., J. Clin. Micro., 26, 231 (Feb. 1988).
Montefiori and Mitchell, Proc. Nat'l Acad. Sci U.S.A., 84(9), 2985 (May 1987).
National Formulary, vol. XII, p. 222.
Nierman, Journal of the Indiana State Medical Association, 45, 497 (1952).
Osbahr, et al., Biochim. Biophys. Acta., 86, 535 (1964).
Pensky and Goldberg, The Journal-Lancet, 75(11), 490 (Nov. 1955).
Pensky and Goldberg, New York State Journal of Medicine, 53, 2238 (1953).
Pharmacopeia of the United States, 15, 379.
Pollner, Medical World News, 35 (Jun. 13, 1988).
Poole, South Med. J., 50, 207 (1957).
Ruggieri, Science, 194, 491 (1976).
Schmeer and Huala, Ann. N.Y. Acad. Sci., 118, 605 (1965).
Schmeer, Science, 144, 413 (1964).
Smith, HIV and Other Highly Pathogenic Viruses, Academic Press, Inc. (1988).
Stillians, Mississippi Valley Medical Journal, 64, 135 (1942).
Stokes and Sternberg, Archives of Dermatology and Syphilology, 40, 345 (1939).
Sutton, Archives of Dermatology and Syphilology, 18, 887 (1928).
Tewksbury and Stahmann, Arch. Biochem. Biophys. (U.S.), 112, 453 (1965).
Tewksbury, Archives Int'l de Pharmacodynamic et de Therapie, 173, 426 (1968).
Tewksbury, Dissertation Abstracts International-Part II, 25-04, 2214 (1964).
Walters, Ohio State Medical Journal, 44, 697 (1948).
Gawish Ali A. S.
Hermann, Jr. William J.
Lawyer Carl H.
Steinbach Thomas
Wagle Sudhakar S.
Kremers-Urban Company
Robinson Douglas W.
Witz Jean C.
LandOfFree
Method of treating hepatitis B infection does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of treating hepatitis B infection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating hepatitis B infection will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1626594